The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy

Clinical Immunology

Volumn 101, Issue 2, 2001, Pages 169-179

  Dyrhol Riise, Anne Ma ^a   Stent, Gianna ^a   Røsok, Bård I ^a   Voltersvik, Pål ^a   Olofsson, Jan ^b   Åsjö, Birgitta ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apoptosis; CD4; CD8; Fas; FasL; HAART; HIV 1; Immune activation; Lymphoid; Therapy; Tonsil

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INDINAVIR; LAMIVUDINE; LIGAND; ZIDOVUDINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LIGHT SCATTERING; LYMPHOID TISSUE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TONSIL; VIRUS LOAD;

EID: 0035178861     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5101     Document Type: Article

References (60)

1. Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion
2. Programmed death of T cells in HIV-1 infection
3. + T cells from human immunodeficiency virus-infected asymptomatic individuals
4. Programmed death of T cells in HIV infection: Result of immune activation?
5. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood
6. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
7. The Fas death factor
8. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
9. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
10. + T cells
11. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
12. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes
13. + T cells by a Fas-independent mechanism
14. Analysis of apoptosis in lymph nodes of HIV-infected persons: Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
15. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
16. + T-cells in tonsillar tissue in HIV type 1 infection
17. Bcl-2 and the regulation of programmed cell death
18. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
19. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method
20. + T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection
21. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
22. + T cell homeostasis and function in advanced HIV disease
23. + cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection
24. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection
25. Apoptosis and the CD95 system in HIV disease: Impact of highly active anti-retroviral therapy (HAART)
26. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis
27. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo
28. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection
29. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection
30. In vivo analysis of Fas/FasL interactions in HIV-infected patients
31. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: Quantitation and virus characterization
32. - T cell subsets in HIV type 1-infected individuals
33. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis
34. Fas transduces activation signals in normal human T lymphocytes
35. + T cells from adults respond to recall antigens after CD28 ligation
36. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
37. + T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists
38. CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1
39. + lymphocyte depletion and human immunodeficiency virus replication
40. + T cells via Fas/Fas ligand-mediated apoptosis
41. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
42. Fas ligand mediates activation-induced cell death in human T lymphocytes
43. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection
44. + T cell apoptosis: A possible mechanism of bystander cell death in HIV infection
45. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
46. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection
47. HIV-specific cytotoxic T lymphocytes in seropositive individuals
48. + T-cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor
49. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
50. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
51. Induction of apoptosis in mature T cells by tumour necrosis factor
52. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection
53. + T cells in HIV type 1 infection
54. - cytotoxic effector clones
55. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition
56. + T cells
57. Comparison of seven quantitative assays to assess lymphocyte cell death during HIV infection: Measurement of induced apoptosis in anti-Fas-treated Jurkat cells and spontaneous apoptosis in peripheral blood mononuclear cells from children infected with HIV
58. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V
59. Activation-driven death of human T cell clones: Time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death
60. T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy